Globally, the loss of PTEN, associated with a reduction of T-cell function and cellularity as well as with increased VEGF production, identifies a common tumor phenotype similar to previous reported data in melanoma, prostate, and glioblastoma tumors. Here, PTEN is linked to melanoma.